Qinghai Biotech Pharmaceutical Group Limited Goodwill

Qinghai Biotech Pharmaceutical Group Limited (0876.HK) currently reports a goodwill of $570M as of June 2026. That compares with $20M in the prior-year period — up 2706.9% year over year. Use the charts on this page to explore Qinghai Biotech Pharmaceutical Group Limited's goodwill history and peer comparisons.

Qinghai Biotech Pharmaceutical Group Limited's goodwill increased from $20M to $570M — a 2706.9% year-over-year increase (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Qinghai Biotech Pharmaceutical Group Limited reported $570M in goodwill as of June 2026. That compares with $20M in the prior-year period — up 2706.9% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current goodwill of $570M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Qinghai Biotech Pharmaceutical Group Limited, and consider following 0876.HK for alerts when major investors trade the stock.